NexPoint Strategic Opportunities Fund
Change company Symbol lookup
Select an option...
NHF NexPoint Strategic Opportunities Fund
FUAPF Global Cannabis Applications Corp
GXG Global X MSCI Colombia ETF
ATMR Altimar Acquisition Corp II
AMD Advanced Micro Devices Inc
BC-A BRUNSWICK 6 500 SENIOR NTS
WST West Pharmaceutical Services Inc
ITT ITT Inc
PLBY Plby Group Inc
SVFA SVF Investment Corp
Go

Company profile

NexPoint Strategic Opportunities Fund (the Trust), formerly NexPoint Credit Strategies Fund, is a non-diversified, closed-end management investment company. The Trust's objective is to provide both current income and capital appreciation. The Trust allocates its investments in public equities, private equity investments, collateralized loan obligation (CLOs) debt, high yield bonds, syndicated floating rate bank loans, real estate assets, CLO equity, non-traditional yield oriented investments and hedge exposure where necessary. The Trust invests in various sectors, which include chemicals, energy, gaming and leisure, housing, media and telecommunications, real estate investment trust, healthcare, asset-backed securities, and information technology. NexPoint Advisers L.P. serves as the investment adviser to the Trust.

Closing Price
$14.22
Day's Change
-0.17 (-1.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
14.44
Day's Low
14.09
Volume
(Heavy Day)
Volume:
204,321

10-day average volume:
81,203
204,321

Vaccine hesitancy falls to lowest level since start of coronavirus pandemic in new poll, but more Americans still need to be persuaded

2:30 pm ET September 1, 2021 (MarketWatch)
Print

Ciara Linnane

Fewer American adults than ever say they will not get vaccinated against the coronavirus that causes COVID-19, and more than ever plan to get children below the age of 12 their shots as soon as the U.S. drug regulator allows it, according to the latest Axios/Ipsos poll.

The new poll is the first to be published since the Food and Drug Administration granted full approval to the vaccine developed by Pfizer Inc. and German partner BioNTech SE(BNTX) on Aug. 23, a move that was expected to help sway some of the hesitant to roll up their sleeves.

The poll found the number of people saying they're not very likely (6%) or not at all likely (14%) to get their shots, shrank to 20%, down from 23% two weeks ago and from 34% in March. That's the smallest number to oppose vaccines since the start of the pandemic.

The number of parents who said they have already gotten their children vaccinated, or will as soon as it's allowed, rose to 68% from 56% two weeks ago and the highest level yet. The number who oppose getting children vaccinated declined to 31%, less than a third, of those polled. There are about 45 million children below the age of 12 in the U.S. who are currently not eligible for vaccination. The FDA is awaiting data from Pfizer (PFE) on a major trial involving children that will be used to decide on the issue.

See:

Axios said there are many factors playing a role in the change in attitudes, including worry about the highly transmissible delta variant, which accounts for the majority of new cases across the U.S.

But the bigger factor is the growing number of organizations, from schools and universities to local governments and private companies, that are mandating vaccination. One in three unvaccinated Americans polled said FDA approval would push them to get the vaccine, while 43% said an employer requiring it would play a role, up from 33% a month ago, as Axios reported.

"Schools, organizations, companies, governments implementing mandates are forcing people to deal with them," said Cliff Young, president of U.S. Public Affairs for Ipsos, according to Axios's report. "That's what going on."

Opinion: Will vaccine skeptics accept the safety of the COVID shot now that the FDA has granted full approval?

See also: With more than 150,000 Americans contracting COVID-19 per day, the price for going unvaccinated is growing

The CDC's vaccine tracker is showing that 173.8 million Americans are fully vaccinated, equal to 52.4% of the overall population. Some 61.7% of Americans have had at least one dose. Among adults 18 and older, 63.4% are fully inoculated, while 74.1% have had at least one dose.

Read: Gen Z students overwhelmingly support strict COVID-19 policies as they return to school

Public health experts have clamored for more people to get vaccinated as most of the new cases, hospitalizations and fatalities in the past several weeks have been among unvaccinated people.

Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and President Joe Biden's chief medical adviser, told CNN at the weekend that up to 100,000 more Americans could die of COVID by December in what he called "both entirely predictable [and] entirely preventable" deaths.

Read on:WHO warns of possible 236,000 new COVID-19 deaths in Europe by December, and Fauci says U.S. could see another 100,000

-Ciara Linnane

	

(END) Dow Jones Newswires

September 01, 2021 14:30 ET (18:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.